Prairie Sky Financial Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$210K Hold
1,500
0.12% 68
2025
Q1
$221K Buy
+1,500
New +$217K 0.13% 69
2024
Q4
Sell
-1,500
Closed -$234K 72
2024
Q3
$234K Hold
1,500
0.13% 72
2024
Q2
$234K Hold
1,500
0.15% 67
2024
Q1
$203K Hold
1,500
0.12% 80
2023
Q4
$202K Hold
1,500
0.13% 74
2023
Q3
$203K Sell
1,500
-500
-25% -$68.3K 0.14% 74
2023
Q2
$286K Buy
+2,000
New +$294K 0.19% 59

Other funds holding AZN

Prairie Sky Financial Group's AZN Position: Q2 2025 in Review

Prairie Sky Financial Group held its AstraZeneca (AZN) position steady in Q2 2025 at 1,500 shares worth $210K. The position accounts for 0.12% of the portfolio, ranked #68.

Prairie Sky Financial Group first reported a position in AZN in Q2 2023 and has held it in 8 quarters since. The position peaked at $286K in Q2 2023. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • Prairie Sky Financial Group held 1,500 shares of AstraZeneca worth $210K as of Q2 2025.
  • Prairie Sky Financial Group left its AstraZeneca share count unchanged in Q2 2025.
  • AstraZeneca made up 0.12% of Prairie Sky Financial Group's portfolio in Q2 2025, its #68 holding.
  • Prairie Sky Financial Group first reported a position in AstraZeneca in Q2 2023 and has held it in 8 quarters since.
  • Prairie Sky Financial Group's AstraZeneca position peaked at $286K in Q2 2023.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Prairie Sky Financial Group's 13F filing for Q2 2025, filed 28 Jul 2025.